← Christina Paitazoglou

Papers by Christina Paitazoglou

Page 1 · newest first

1. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionJournal of the American College of Cardiology · 2021
2. Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure: Exploratory Analysis of the PRELIEVE studyESC Heart Failure · 2026
3. Patient-reported outcomes and experiences in a regional heart failure care network in northern Germany: a mixed-methods study2026
4. Stem-Cell–Derived Biologic Ventricular Assist Tissue in Heart FailureNew England Journal of Medicine · 2026
5. Left Atrial Appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trialAmerican Heart Journal · 2026
6. Hemodynamic Assessment in Takotsubo SyndromeJournal of the American College of Cardiology · 2023
7. A Heart Failure Network Model to Improve Outcome and Trans-Sectoral Guideline-Directed Medical Treatment UtilizationESC Heart Failure · 2025
8. Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomesEuropean Journal of Heart Failure · 2025
9. Lp(a) in daily clinical routine: risk-factor for both cardiovascular events and heart-failure? A retrospective analysis of the Luebeck Lp(a) heart-failure (HF) registry in patients after myocardial infarctionAtherosclerosis Plus · 2025
10. Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF2-DZHK05) trial: Baseline Characteristics and Comparison to Other Relevant Clinical TrialsEuropean Journal of Heart Failure · 2025
11. Intravenous Ferric Carboxymaltose in Heart Failure With Iron DeficiencyJAMA · 2025
12. Steerable Delivery Sheath for Optimized LAA Closure: First Experience and Procedural OutcomesCatheterization and Cardiovascular Interventions · 2024
13. Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite AnticoagulationJAMA Neurology · 2024
14. Patient knowledge about risk factors, achievement of target values, and guideline-adherent secondary prevention therapies 12 months after acute myocardial infarctionEuropean Heart Journal Acute Cardiovascular Care · 2024
15. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation ContraindicationJACC: Cardiovascular Interventions · 2024
16. Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registryCatheterization and Cardiovascular Interventions · 2023
17. Predicted Impact of Atrial Flow Regulator on Survival in Heart Failure with Reduced and Preserved Ejection FractionESC Heart Failure · 2023
18. Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registryCatheterization and Cardiovascular Interventions · 2023
19. Effect of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cell Treatment in Chronic Ischaemic Heart Failure with Reduced Ejection Fraction – the SCIENCE TrialEuropean Journal of Heart Failure · 2023
20. Lack of correlation between different congestion markers in acute decompensated heart failureClinical Research in Cardiology · 2022
21. Atrial Giant Cell Myocarditis as a Cause of Heart FailureJACC Case Reports · 2022
22. One‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE studyEuropean Journal of Heart Failure · 2021
23. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionEuroIntervention · 2019
24. Rationale and Design of the European Multicentre Study on Stem Cell Therapy in IschEmic Non-Treatable Cardiac diseasE (SCIENCE)European Journal of Heart Failure · 2019